Approaches to reduce antibiotic resistance in the community

Pediatric Infectious Disease Journal

Volumn 25, Issue 10, 2006, Pages 977-980

  Cohen, Robert ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

Antibiotic prescriptions; Antibiotic resistance; Pneumococcal conjugate vaccine

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEPHALOSPORIN DERIVATIVE; CHICKENPOX VACCINE; COTRIMOXAZOLE; INFLUENZA VACCINE; MACROLIDE; PENICILLIN DERIVATIVE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL FLORA; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHICKENPOX; CHILD HEALTH CARE; CHILDHOOD DISEASE; COMMUNITY ACQUIRED PNEUMONIA; DRUG DOSE REGIMEN; EMERGENCY MEDICINE; HUMAN; IMMUNIZATION; INFLUENZA; LOW DRUG DOSE; NASOPHARYNX; NONHUMAN; PERTUSSIS; PHARYNGITIS; PRESCRIPTION; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT DURATION; VACCINATION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; DRUG PRESCRIPTIONS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HEALTH POLICY; HUMANS; PRESCRIPTIONS, DRUG; SELECTION (GENETICS); SELECTION, GENETIC; VACCINATION;

EID: 33749440859     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000239271.10784.1e     Document Type: Article

References (39)

1. Levy S. Antibiotic resistance: the problem intensifies. Adv Drug Deliv Rev. 2005;57:1446-1450.
2. Doern GV. Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract. Am J Med. 1995;99:3S-7S.
3. Moreno S, García-Leoni M, Cercenado E, Diaz MD, Bernaldo de Quirós JC, Bouza E. Infections caused by erythromycin-resistant Streptococcus pneumoniae: incidence, risk factors, and response to therapy in a prospective study. Clin Infect Dis. 1995;20:1195-1200.
4. Davidson R, Cavalcanti R, Brunton JL, et al. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med. 2002;346:747-750.
5. Siberry G, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis. 2003;37:1257-1260.
6. Goossens H, Ferech M, Vander Stichele R, Elseviers M, for the ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study Lancet. 2005;365:579-587.
7. Tan TQ, Mason EO, Kaplan SL. Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics. 1993;92:761-767.
8. Cohen R, Bingen E, Varon E, et al. Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children. Pediatr Infect Dis. 1997;16:555-560.
9. Brown P, Freeman A, Foxman B. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Clin Infect Dis. 2002;34:1061-1066.
10. Mainous A, Hueston W, Clark J. Antibiotics and upper respiratory infection: do some folks think there is a cure for the common cold? J Fam Pract. 1996;42:357-361.
11. Nyquist A-C, Gonzales R, Steiner JF, Sande M. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA. 1998;279:875-877.
12. Belongia E, Sullivan B, Chyou PH, Madagame E, Reed K, Schwartz B. A community intervention trial to promote judicious antibiotic use and reduce penicillin-resistant streptococcus pneumoniae Carriage in Children. Pediatrics. 2001;108:575-583.
13. Hennessy T, Petersen K, Bruden D, et al. Changes in antibiotic- prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: a controlled intervention trial in rural Alaska. Clin Infect Dis. 2002;34:1543-1550.
14. Finkelstein J, Davis R, Dowell S, et al. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics. 2001;108:1-7.
15. Taylor J, Kwan-Gett J, McMahon E. Effectiveness of a parenteral educational intervention in reducing antibiotic use. Pediatr Infect Dis J. 2005;24:489-493.
16. Arnold S, To T, McIsaac W, Wang E. Antibiotic prescribing for upper respiratory tract infection: the importance of diagnostic uncertainty. J Pediatr. 2005;146:222-226.
17. Cizman M, Srovin T, Pokorn M, Cad Pecar S, Battelino S. Analysis of the causes and consequences of decreased antibiotic consumption over the last 5 years in Slovenia. J Antimicrob Chemother. 2005;55:758-763.
18. Guillemot D. Evolution of antibiotic consumption in ambulatory practice 2002-2004. Available at: http://www.ameli.fr/174/DOC/1564/dp.html.
19. Noyola D, Demmler G. Effect of rapid diagnosis on management of influenza A infections. Pediatr Infect Dis J. 2000;19:303-307.
20. Sharma V, Dowd D, Slaughter AJ, Simon SD. Effect of rapid diagnosis of influenza virus type A on the emergency department management of febrile infants and toddlers. Arch Pediatr Adolesc Med. 2002;156:41-43.
21. Bonner, A Monroe K, Talley L, Klasner A, Kimberlin D. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a trial. Pediatrics. 2003;112:363-367.
22. Van Zuijlen D, Schilder A, Van Balen F, Hoes A. National differences in incidence of acute mastoiditis: relationship to prescribing patterns for acute otitis media. Pediatr Infect Dis J. 2001;20:140-144.
23. Little P, Watson L, Morgan S, Williamson I. Antibiotic prescribing and admissions with major suppurative complications of respiratory tract infections: a data linkage study. Br J Gen Pract. 2002;52:187-190.
24. Sharland M, Kendall H, Yeates D, et al. Antibiotic prescribing in general practice and hospital admissions for peritonsillar abscess mastoiditis, and rheumatic fever in children: time trend analysis. BMJ. 2005;331:328-329.
25. Dagan R, Lipsitch M. Changing the ecology of pneumococci with antibiotics and vaccines. In: Tuomanen EI, ed. The Pneumococcus. Washington, DC: ASM Press; 2004:283-313.
26. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland: Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997;337:441-446.
27. Bergman M, Huikko S, Pihlajamaki M, et al. Finnish Study Group for Antimicrobial Resistance (FiRe Network). Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin Infect Dis. 2004;38:1251-1256.
28. Guillemot D, Carbon C, Balkau B, et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA. 1998;279:365-370.
29. Schrag S, Pena C, Fernandez J, et al. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. JAMA. 2001;286:49-56.
30. Bingen E, Leclercq R, Fitoussi F, et al. Emergence of group A streptococcus strains with different mechanisms of macrolide resistance. Antimicrob Agents Chemother. 2002;46:1199-1203.
31. Neuzil K, Mellen B, Wright P, Mitchel E, Griffin M. Effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342:225-231.
32. Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA. 2000;284:1655-1663.
33. Nichol KL, Mendelman PM, Mallon KP, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 1999;281:137-144.
34. Dagan R, Sikuler-Cohen M, Zamir O, Janco J, Givon-Lavi N, Fraser D. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatr Infect Dis J. 2001;20:951-958.
35. Givon-Lavi N, Fraser D, Dagan R. Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings. Pediatr Infect Dis J. 2003;22:524-532.
36. Talbot T, Poehling K, Hartert T, et al. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2004;39:641-648.
37. Cohen R, Levy C, de La Rocque F, et al. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Pediatr Infect Dis J. 2006, in press.
38. Huang S, Platt R, Rifas-Shiman S, Pelton S, Goldmann D, Finkelstein J. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics. 2005;116:e408-413.
39. Porat N, Arguedas A, Spratt BG, et al. Emergence of penicillin- nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine. J Infect Dis. 2004;190:2154-2161.